JPRN-UMIN000017471已完成2 期
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with refractory germ cell cancer - chemotherapy with gemcitabine plus oxaliplatin for refractory germ cell cancer
Department of Urology, Tohoku University Graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2015年5月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.patient with symptomatic interstitial pneumonia 2.patient with grade 3 or 4 cardiac insufficiency with NYHA classification 3.patient with severe infection 4.patient with severe comorbidity 5.patient with severe allergy 6.patient with active another malignancy
研究者
相似试验
已完成
不适用
eoadjuvant combined chemotherapy with gemcitabine, cisplatin and zoledronic acid against muscle invasive bladder cancerbladder cancerJPRN-UMIN000003146Department of Urology, Graduate School of Biomedical Sciences Hiroshima University30
已完成
2 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.pancreas cancer10017991Pancreatic cancerNL-OMON36705Vrije Universiteit Medisch Centrum63
进行中（未招募）
1 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.Inoperable locally advanced pancreatic cancer.MedDRA version: 12.1Level: LLTClassification code 10033606Term: Pancreatic cancer non-resectableEUCTR2010-018327-26-NLVU University Medical Center
已完成
2 期
eoadjuvant chemotherapy with gemcitabin plus carboplatin for triple negative breast cancerbreast cancerJPRN-UMIN000030215Showa University30
招募中
2 期
Chemotherapy using gemcitabine and docetaxel for advanced bone and soft tissue sarcomaadvanced bone and soft tissue tumorJPRN-UMIN000021202agoya City University, Graduate School of Medical Science10